Randomized phase III trial of sorafenib versus placebo in patients with advanced hepatocellular carcinoma (HCC)

被引：0

作者：

Llovet, J.

Ricci, S.

Mazzaferro, V.

Hilgard, P.

Raoul, J.

Zeuzem, S.

Poulin-Costello, M.

Moscovici, M.

Voliotis, D.

Bruix, J.

机构：

[1] Mt Sinai Sch Med, New York, NY USA

[2] St Chiara Univ Hosp, Pisa, Italy

[3] Natl Canc Inst, Milan, Italy

[4] Univ Hosp Essen, Essen, Germany

[5] Ctr Eugene Marquis, Rennes, France

[6] JW Goethe Univ Hosp, Frankfurt, Germany

[7] Bayer HealthCare, Toronto, ON, Canada

[8] Bayer SpA PH, Milan, Italy

[9] Bayer HealthCare, Wuppertal, Germany

[10] Hosp Clin Barcelona, Barcelona, Spain

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA1

引用

页数：1